<?xml version="1.0" encoding="UTF-8"?>
<p>KBP recently cloned a portion of the genetic sequence of COVID-19, which led to the development of a potential antigenâ€”a substance that induces an immune response to the body and particularly stimulates antibody production. This antigen was then inserted into tobacco plants for reproduction. After the plants were harvested, the antigen was purified and is currently undergoing pre-clinical testing (
 <xref rid="B99" ref-type="bibr">99</xref>). The pharmaceutical industry and health authorities argue that there are significant efforts to diagnose, treat, and prevent infections with the new coronavirus.
</p>
